Significantly high expression of platelet-derived growth factor (PDGF) in benign nodules of the thyroid: Relevance in the development of goitre recurrence?

Langenbeck's Archives of Surgery

Volumn 396, Issue 8, 2011, Pages 1165-1172

  Malkomes, Patrizia ^a   Oppermann, Elsie ^a   Bechstein, Wolf Otto ^a   Holzer, Katharina ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

PDGF; PDGF receptor; Recurrent goitre; Thyroid

Indexed keywords

MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR CC; PLATELET DERIVED GROWTH FACTOR DD; RNA; UNCLASSIFIED DRUG;

CELL CULTURE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NODULAR GOITER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; THYROID CELL; THYROID NODULE; WESTERN BLOTTING;

ADULT; AGED; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; BLOTTING, WESTERN; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GOITER, NODULAR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECURRENCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; THYROID NODULE;

EID: 82355182817     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-011-0799-2     Document Type: Conference Paper

References (35)

1. R Ross J Glosmet B Kariya H Laurence 1974 A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro Proc Natl Acad Sci 7 1207 1210 10.1073/pnas.71.4.1207
2. L Fredriksson H Li U Eriksson 2004 The PDGF family: four gene products form five dimeric isoforms Cytokine Growth Factor Rev 15 197 204 15207811 10.1016/j.cytogfr.2004.03.007 1:CAS:528:DC%2BD2cXltVKht7g%3D (Pubitemid 38781045)
3. X Li A Ponten K Aase L Karlsson A Abramsson M Uutela G Backstrom M Hellstrom H Bostrom H Li P Soriano C Betsholtz CH Heldin K Alitalo A Ostman U Eriksson 2000 PDGF-C is a new protease-activated ligand for the PDGF-receptor Nat Cell Biol 2 302 309 10806482 10.1038/35010579 1:CAS:528:DC%2BD3cXktlygtrw%3D
4. E Bergsten M Uutela X Li K Pietras A Ostman CH Heldin K Alitalo U Eriksson 2001 PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor Nat Cell Biol 3 512 516 11331881 10.1038/35074588 1:CAS:528:DC%2BD3MXjsFCks74%3D (Pubitemid 32422089)
5. WJ LaRochelle M Jeffers WF McDonald 2001 PDGF-D, a new protease-activated growth factor Nat Cell Biol 3 517 521 11331882 10.1038/35074593 1:CAS:528:DC%2BD3MXjsFCks78%3D (Pubitemid 32422090)
6. C-H Heldin A Wasteson B Westermark 1985 Platelet-derived growth factor Mol Cell Endocrinol 39 169 187 2984061 10.1016/0303-7207(85)90061-9 1:CAS:528:DyaL2MXht1Gltbw%3D (Pubitemid 15134942)
7. TF Deuel JS Huang 1984 Platelet-derived growth factor. Structure, function, and roles in normal and transformed cells J Clin Invest 74 669 676 6088582 10.1172/JCI111482 1:CAS:528:DyaL2cXlsVChurg%3D (Pubitemid 14031001)
8. M Li V Jendrossek C Belka 1995 The role of PDGF in radiation oncology Radiat Oncol 2 5 10.1186/1748-717X-2-5 1:CAS:528:DyaK28XjtFalsbY%3D
9. B Westermark 1995 Platelet-derived growth factor. A growth factor of great physiopathological importance Lakartidningen 7 92(23) 2397 2401
10. K-T Chen J-D Lin M-J Liou H-F Wenig CA Chang EC Chan 2006 An aberrant autocrine activation of the platelet-derived growth factor α-receptor in follicular and papillary thyroid carcinoma cell lines Cancer Lett 231 192 205 16126335 10.1016/j.canlet.2005.01.039 1:CAS:528:DC%2BD28XhsFGgtA%3D%3D (Pubitemid 43038730)
11. NE Heldin B Gustavsson L Claesson-Welsh A Hammacher J Mark CH Heldin B Westermark 1988 Aberrant expression of receptors for platelet-derived growth factor in an anaplastic thyroid carcinoma cell line Proc Natl Acad Sci 85 23 9302 9306 2848260 10.1073/pnas.85.23.9302 1:CAS:528:DyaL1MXjslartQ%3D%3D (Pubitemid 19001885)
12. Y Yano N Uematsu T Yashiro H Hara E Ueno M Miwa G Tsujimoto Y Aiyoshi K Uchida 2004 Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma Clin Cancer Res 10 2035 2043 15041723 10.1158/1078-0432.CCR-0807-03 1:CAS:528: DC%2BD2cXisVGksr4%3D (Pubitemid 38375564)
13. M Derwahl 1998 Von der diffusen Struma zur Knotenstruma Internist 39 577 583 9677512 10.1007/s001080050214 1:STN:280:DyaK1czkt1CktA%3D%3D (Pubitemid 28297982)
14. K Westermark M Lundqvist G Wallin T Dahlman GW Hacker NE Heldin L Grimelius 1996 EGF-receptors in human normal and pathological thyroid tissue Histopathology 28 3 221 227 8729040 10.1046/j.1365-2559.1996.d01-427.x 1:STN:280:DyaK283ns1SrsQ%3D%3D (Pubitemid 26088729)
15. C-H Heldin B Westermark 1999 Mechanism of action and in vivo role of platelet-derived growth factor Physiol Rev 79 1283 1316 10508235 1:CAS:528:DyaK1MXmvVymtLY%3D (Pubitemid 29473317)
16. RM Reis A Martins SA Ribeiro D Basto A Longatto-Filho FC Schmitt JM Lopes 2005 Molecular characterization of PDGFR-alpha/PDGF-A and c-KIT/SCF in gliosarcomas Cell Oncol 27 319 326 16373964 1:CAS:528:DC%2BD2MXhtlCnsr3I (Pubitemid 41831637)
17. K Anan T Morisaki M Katano A Ikubo H Kitsuki A Uchiyama S Kuroki M Tanaka M Torisu 1996 Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer Surgery 119 3 333 339 8619189 10.1016/S0039-6060(96)80120-6 1:STN:280: DyaK283gt1Gmtg%3D%3D (Pubitemid 26082669)
18. C Sundberg M Branting B Gerdin K Rubin 1997 Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells Am J Pathol 151 2 479 492 9250160 1:CAS:528:DyaK2sXls1Wms70%3D (Pubitemid 27330067)
19. L Uhrbom G Hesselager A Ostman M Nistér B Westermark 2000 Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells Int J Cancer 85 3 398 406 10652433 10.1002/(SICI)1097-0215(20000201)85:3<398::AID-IJC17>3.0.CO;2-L 1:CAS:528:DC%2BD3cXmsVCgug%3D%3D (Pubitemid 30030415)
20. F Torino SM Corsello R Longo A Barnabei G Gasparini 2009 Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy Nat Rev Clin Oncol 6 4 219 228 19333228 10.1038/nrclinonc.2009.4 1:CAS:528:DC%2BD1MXktVCmtL4%3D
21. D Mannavola P Coco G Vannucchi R Bertuelli M Carletto PG Casali P Beck-Peccoz L Fugazzola 2007 A novel tyrosine-kinase selective inhibitor, sunitinib, induces transient hypothyroidism by blocking iodine uptake J Clin Endocrinol Metab 92 9 3531 3534 17595247 10.1210/jc.2007-0586 1:CAS:528:DC%2BD2sXhtVGqsrnK (Pubitemid 47435331)
22. J Sun DA Wang RK Jain A Carie S Paquette E Ennis MA Blaskovich L Baldini D Coppola AD Hamilton SM Sebti 2005 Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors Oncogene 24 29 4701 4709 15897913 10.1038/sj.onc.1208391 1:CAS:528:DC%2BD2MXlvVGhs7k%3D (Pubitemid 41032606)
23. M Vaiman A Nagibin P Hagag A Buyankin J Olevson N Shlamkovich 2008 Subtotal and near total versus total thyroidectomy for the management of multinodular goiter World J Surg 32 1546 1551 18340482 10.1007/s00268-008-9541-9
24. KL Snook PLH Stalberg SB Sidhu MS Sywak P Edhouse L Delbridge 2007 Recurrence after total thyroidectomy for benign multinodular goiter World J Surg 31 593 598 17308855 10.1007/s00268-006-0135-0 (Pubitemid 46356070)
25. J Moalem I Suh Q-Y Duh 2008 Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature World J Surg 32 1301 1312 18305998 10.1007/s00268-008-9477-0
26. H Gibelin M Sierra D Mothes P Ingrand P Levillain C Jones S Hadjadj F Torremocha R Marechaud J Barbier J-L Kraimps 2004 Risk factors for recurrent nodular goiter after thyroidectomy for benign diseases: case-control study of 244 patients World J Surg 28 1079 1082 15490059 10.1007/s00268-004-7607-x (Pubitemid 40109854)
27. G Basili C Biagini A Manetti F Martini G Biliotti 2004 Risk of recurrence following partial thyroidectomy for benign lesions. Report of 58 patients 15-25 years after surgery Minerva Chir 58 321 329 (Pubitemid 37314161)
28. K Sato M Miyakawa N Onoda H Demura T Yamashita M Miura T Kasajima K Yamazaki T Obara 1997 Increased concentration of vascular endothelial growth factor/vascular permeability factor in cyst fluid of enlarging and recurrent thyroid nodules J Clin Endocrinol Metab 82 1968 1973 9177415 10.1210/jc.82.6.1968 1:CAS:528:DyaK2sXjs1Gku7o%3D (Pubitemid 127495219)
29. DJ Hicklin LM Ellis 2005 Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis J Clin Oncol 23 5 1011 1027 15585754 10.1200/JCO.2005.06.081 1:CAS:528:DC%2BD2MXit1Gnsro%3D (Pubitemid 46202320)
30. D Wang HJ Huang A Kazlauskas WK Cavenee 1999 Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase Cancer Res 59 7 1464 1472 10197615 1:CAS:528:DyaK1MXisVWktb8%3D (Pubitemid 29160112)
31. W Lederle H-J Stark M Skobe NE Fusenig MM Mueller 2006 Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells Am J Pathol 169 5 1767 1783 17071599 10.2353/ajpath.2006.060120 1:CAS:528:DC%2BD28Xht12isr3M (Pubitemid 351182007)
32. MR Kano Y Morishita C Iwata S Iwasaka T Watabe Y Ouchi K Miyazono K Miyazawa 2005 VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling J Cell Sci 118 16 3759 3768 16105884 10.1242/jcs.02483 1:CAS:528:DC%2BD2MXhtVaktrnP (Pubitemid 41309422)
33. A Ríos Zambudio JM Rodríguez González PJ Galindo Fernández MJ Montoya Tabares M Canteras Jordana P Parilla Paricio 2005 Clinical recurrence of multinodular goitre after surgery. A multivariate study on the risk factors Rev Clín Esp 205 1 9 13 15718011 10.1157/13070752 (Pubitemid 40340388)
34. R Phitayakorn DM Super CR McHenry 2006 An investigation of epidemiologic factors associated with large nodular goiter J Surg Res 133 1 16 21 16690367 10.1016/j.jss.2006.02.044 1:STN:280:DC%2BD283msFygug%3D%3D
35. A Ríos JM Rodríguez M Canteras PJ Galindo MD Balsalobre P Parrilla 2004 Risk factors for malignancy in multinodular goiters Eur J Surg Oncol 30 1 58 62 14736524 10.1016/j.ejso.2003.10.021 (Pubitemid 38185765)